Loading...

Brilliant Violet 605™ anti-human CD103 (Integrin αE) Antibody

Pricing & Availability
Clone
Ber-ACT8 (See other available formats)
Regulatory Status
RUO
Workshop
V A067
Other Names
Integrin alpha E (ITGAE)
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
Ber-ACT8_BV605_CD103_Antibody_1_091924
PHA-stimulated (3 days) human peripheral blood lymphocytes were stained with CD3 APC/Cyanine7 and CD103 (clone Ber-ACT8) Brilliant Violet 605™ (left) or mouse IgG1, κ Brilliant Violet 605™ isotype control (right).
  • Ber-ACT8_BV605_CD103_Antibody_1_091924
    PHA-stimulated (3 days) human peripheral blood lymphocytes were stained with CD3 APC/Cyanine7 and CD103 (clone Ber-ACT8) Brilliant Violet 605™ (left) or mouse IgG1, κ Brilliant Violet 605™ isotype control (right).
Compare all formats See Brilliant Violet 605™ spectral data
Cat # Size Price Quantity Check Availability Save
350217 25 tests 164€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
350218 100 tests 344€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD103 is a type I transmembrane glycoprotein also known as αE integrin, integrin αIEL chain, and human mucosal lymphocyte antigen 1. It belongs to the integrin family and is primarily found on intestinal intraepithelial lymphocytes (IEL). CD103 is also expressed on a subpopulation of lamina propria T cells, epithelial dendritic cells, lamina propria-derived dendritic cells, and a small subset of peripheral lymphocytes. Treg cells express high level of CD103. Hairy cell leukemia has also been shown to express CD103. The expression of CD103 on lymphocytes can be induced upon activation and TGF-β stimulation. In association with integrin β7, CD103 is expressed as an αE/β7 heterodimer. Mature CD103 protein can be cleaved into 2 chains, a 150 kD (C-terminal) chain and a 25 kD (N-terminal) chain, which remain linked by disulfide bonds. CD103 binds to E-cadherin and mediates homing of lymphocytes to the intestinal epithelium.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Reported Reactivity
Cynomolgus
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
HTLV-1 induced human T cell line MAPS16
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 605™ under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Brilliant Violet 605™ excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported applications (for the relevant formats) include: Western Blotting1, immunoprecipitation1, and immunohistochemical staining of frozen tissue sections1.

Application References

(PubMed link indicates BioLegend citation)
  1. Kruschwitz M, et al. 1991. J. Clin. Pathol. 44:636. (WB, IP, IHC-F)
  2. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
Product Citations
  1. Adamo S, et al. 2023. Cell Host Microbe. 31:928. PubMed
  2. Eiva MA, et al. 2022. Eur J Immunol. 52:96. PubMed
  3. Iwahori K, et al. 2019. Sci Rep. 2.205555556. PubMed
  4. Cella M, et al. 2019. Nat Immunol. 1.513888889. PubMed
  5. Barrow AD et al. 2018. Cell. 172(3):534-548 . PubMed
  6. Swadling L, et al. 2020. Cell Rep. 30:687. PubMed
  7. Kollis PM, et al. 2022. Front Immunol. 13:850226. PubMed
  8. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  9. Buggert M, et al. 2020. Cell. 183(7):1946-1961.e15. PubMed
  10. Collins PL et al. 2018. Cell. 176(1-2):348-360 . PubMed
  11. Singh A, et al. 2020. Cell Rep. 32:108153. PubMed
  12. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
RRID
AB_2564282 (BioLegend Cat. No. 350217)
AB_2564282 (BioLegend Cat. No. 350218)

Antigen Details

Structure
Type I transmembrane glycoprotein, integrin family; can be cleaved into 150 kD and 25 kD chains; associated with β7 integrin
Distribution

Majority of intestinal intraepithelial lymphocytes (IEL), subpopulation of lamina propria T cells, epithelial dendritic cells, small subset of peripheral lymphocytes, Treg cells; expressed on hairy cell leukemia

Function
Retention and activation of CD103+ lymphocytes in the intestinal epithelium, regulation of tissue-specific T cell homing
Ligand/Receptor
E-Cadherin
Cell Targets
Integrin β7
Cell Type
Dendritic cells, Lymphocytes, T cells, Tregs
Biology Area
Cell Biology, Immunology, Neuroscience, Synaptic Biology
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Parker CM, et al. 1992. P. Natl. Acad. Sci. USA 89:1924.
2. Kruschwitz M, et al. 1991. J. Clin. Pathol. 44:636.
3. Schon MP, et al. 1999. J. Immunol. 162:6641.
4. Shaw SK, et al. 1994. J. Biol. Chem. 269:6016.

Gene ID
3682 View all products for this Gene ID
UniProt
View information about CD103 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD103 Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-human CD103 (Integrin αE) Ber-ACT8 FC,WB,IP,IHC-F
FITC anti-human CD103 (Integrin αE) Ber-ACT8 FC
PE anti-human CD103 (Integrin αE) Ber-ACT8 FC
Alexa Fluor® 488 anti-human CD103 (Integrin αE) Ber-ACT8 FC
Alexa Fluor® 647 anti-human CD103 (Integrin αE) Ber-ACT8 FC
PE/Cyanine7 anti-human CD103 (Integrin αE) Ber-ACT8 FC
Brilliant Violet 421™ anti-human CD103 (Integrin αE) Ber-ACT8 FC
APC anti-human CD103 (Integrin αE) Ber-ACT8 FC
Brilliant Violet 605™ anti-human CD103 (Integrin αE) Ber-ACT8 FC
Biotin anti-human CD103 (Integrin αE) Ber-ACT8 FC
Brilliant Violet 711™ anti-human CD103 (Integrin αE) Ber-ACT8 FC
PE/Dazzle™ 594 anti-human CD103 (Integrin αE) Ber-ACT8 FC
PerCP/Cyanine5.5 anti-human CD103 (Integrin αE) Ber-ACT8 FC
Brilliant Violet 785™ anti-human CD103 (Integrin αE) Ber-ACT8 FC
APC/Cyanine7 anti-human CD103 (Integrin αE) Ber-ACT8 FC
TotalSeq™-A0145 anti-human CD103 (Integrin αE) Ber-ACT8 PG
TotalSeq™-C0145 anti-human CD103 (Integrin αE) Ber-ACT8 PG
TotalSeq™-B0145 anti-human CD103 (Integrin αE) Ber-ACT8 PG
APC/Fire™ 750 anti-human CD103 (Integrin αE) Ber-ACT8 FC
PE/Fire™ 700 anti-human CD103 (Integrin αE) Antibody Ber-ACT8 FC
TotalSeq™-D0145 anti-human CD103 (Integrin αE) Ber-ACT8 PG
PE/Fire™ 640 anti-human CD103 (Integrin αE) Ber-ACT8 FC
PE anti-human CD103 Ber-ACT8 FC
FITC anti-human CD103 Ber-ACT8 FC
APC anti-human CD103 Ber-ACT8 FC
Spark YG™ 581 anti-human CD103 (Integrin αE) Ber-ACT8 FC
Spark NIR™ 685 anti-human CD103 (Integrin αE) Ber-ACT8 FC
Spark Blue™ 550 anti-human CD103 (Integrin αE) Ber-ACT8 FC
PE/Fire™ 810 anti-human CD103 (Integrin αE) Ber-ACT8 FC
GMP FITC anti-human CD103 (Integrin αE) Ber-ACT8 FC
GMP PE anti-human CD103 (Integrin αE) Ber-ACT8 FC
Spark Red™ 718 anti-human CD103 (Integrin αE) (Flexi-Fluor™) Ber-ACT8 FC
Spark Blue™ 574 anti-human CD103 (Integrin αE) (Flexi-Fluor™) Ber-ACT8 FC
Go To Top Version: 1    Revision Date: 09/24/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account